About OICR, MaRS Centre Toronto
OICR, MaRS Centre Toronto: Accelerating Cancer Research Discoveries for Patients Worldwide
OICR (Ontario Institute for Cancer Research) is a not-for-profit research institute located in the heart of Toronto's MaRS Centre. The institute was established in 2005 with a mission to accelerate the development of cancer research discoveries for patients around the world. OICR is funded by the Government of Ontario through its Ministry of Economic Development, Job Creation and Trade.
The institute has a team of over 400 researchers, scientists, clinicians and support staff who work together to advance cancer research through collaboration and innovation. OICR's research programs cover a wide range of areas including genomics, drug discovery, imaging technology and clinical trials.
One of OICR's key strengths is its ability to bring together researchers from different disciplines to work on common goals. This collaborative approach has led to many breakthroughs in cancer research over the years. For example, OICR played a key role in developing an innovative new treatment for acute myeloid leukemia (AML), which has shown promising results in clinical trials.
OICR also works closely with industry partners to translate its discoveries into new treatments and therapies that can benefit patients worldwide. The institute has established partnerships with leading pharmaceutical companies such as Pfizer and GlaxoSmithKline as well as biotech startups like Turnstone Biologics.
In addition to its research programs, OICR also provides training opportunities for young scientists through its fellowship program. This program offers postdoctoral fellows the chance to work alongside experienced researchers on cutting-edge projects that have real-world impact.
Overall, OICR is an important player in the global fight against cancer. Its collaborative approach and focus on innovation have led to many significant breakthroughs that are improving outcomes for patients around the world. With continued support from government funders and industry partners alike, there is no doubt that OICR will continue making important contributions towards our understanding of this complex disease.
SEO-Optimized Keywords:
- Ontario Institute for Cancer Research
- MaRS Centre Toronto
- not-for-profit research institute
- cancer research discoveries
- genomics
- drug discovery
- imaging technology
- clinical trials
- acute myeloid leukemia
- industry partnerships
- Pfizer
-GlaxoSmithKline
-Turnstone Biologics
-fellowship program